Nalaganje...
Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system
BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...
Shranjeno v:
| izdano v: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750847/ https://ncbi.nlm.nih.gov/pubmed/31571995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217375 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|